Novel M(II) beta-diketiminate complexes for the polymerization of lactide

Diketimine ligands bearing N-benzyl, N-9-anthrylmethyl and N-mesitylmethyl substituents (nacnacBnH, nacnacAnH, and nacnacMesH) were prepared from condensation of amine with either acetyl acetone or its ethylene glycol monoketal. Chlorination of the 3-position was achieved using N-chlorosuccinimide, yielding ClnacnacBnH and ClnacnacAnH. The 3-position was also substituted by succinimido by lithiation of nacnacBnH followed by reaction with N-chlorosuccinimide (3-succinimido-nacnacBnH). N-aryl ligands nacnacippH and nacnacNaphH (ipp = 2-isopropylphenyl, Naph = 1-naphthyl) were prepared from literature. The ligands were reacted with Zn(TMSA)2 (TMSA = N(SiMe3)2) to yield  nacnacAnZn(TMSA) and  ClnacnacBnZn(TMSA). Protonation with isopropanol gave nacnacAnZnOiPr and ClnacnacBnZnOiPr. Reaction of the diketimines with Mg(TMSA)2 afforded nacnacAnMg(TMSA), nacnacMesMg(TMSA), ClnacnacBnMg(TMSA) and  ClnacnacAnMg(TMSA). Subsequent protonation with tert-butanol produced nacnacMesMgOtBu and ClnacnacBnMgOtBu, but only decomposition was observed with N-anthrylmethyl substituents. Reaction of the diketimines with Cu(OiPr)2 yielded the heteroleptic [nacnacBnCu(μ-OiPr)]2 and [3-Cl-nacnacBnCu(μ-OiPr)]2 when using sterically undemanding ligands. When sterically more demanding diketimines were used, stabilization of the heteroleptic complex by dimerization was not possible, resulting in the formation of the homoleptic complexes Cu(nacnacipp)2 and Cu(nacnacNaph)2 by ligand exchange. Homoleptic complexes were also prepared with N-benzyl ligands, i. e. Cu(nacnacBn)2 and Cu(3-succinimido-nacnacBn)2. Even bulkier ligands such as nacnacAnH, nacnacMesH or N-methylbenzyl substituents failed to react with Cu(OiPr)2. Most complexes were characterized by single crystal X-ray diffraction. TMSA complexes and homoleptic complexes were monomeric, alkoxide complexes were dimeric in the solid state. All alkoxide complexes, as well as nacnacAnMg(TMSA)/BnOH and ClnacnacAnMg(TMSA)/BnOH were moderately to highly active in rac-lactide polymerization (90% conversion in 30 sec to 3 h). nacnacAnZnOiPr produced highly heterotactic polymer (Pr = 0.90), ClnacnacBnMgOtBu/BnOH produced slightly isotactic polymer at –30 °C (Pr = 0.43), all other catalysts produced atactic polymers with a slight heterotactic bias (Pr = 0.48 – 0.55). Heteroleptic complexes [nacnacBnCu(μ-OiPr)]2 and [3-Cl-nacnacBnCu(μ-OiPr)]2 are very highly active rac-lactide polymerization catalysts, with complete monomer conversion at ambient temperature in solution in 0.5 – 5 min. [nacnacBnCu(μ-OiPr)]2 specifically polymerized in the presence or absence of isopropanol as a chain-transfer reagent with very high activity (k2 = 32 M–1•s–1), in methylene chloride. While in acetonitrile, THF, dichloromethane and toluene has a kobs = 2.4(1), 5.3(5), 3.6-4.4 and 10(1) min–1, respectively. [nacnacBnCu(μ-OiPr)]2 yields narrow polydispersities and no evidence of side reactions such as transesterification, epimerization or catalyst decomposition. The homoleptic complexes in the presence of free alcohol, seem to be in equilibrium with small amounts of the respective heteroleptic complex, which are sufficient to complete polymerization in less than 60 min at room temperature. All Cu catalysts show high control of polymerization with polydispersities of 1.1 and below. The obtained polymers were essentially atactic, with a slight heterotactic bias at ambient temperature and at –17 °C. [nacnacBnCu(μ-OiPr)]2 polymerizes -butyrolactone (BL), -caprolactone (CL) and -valerolactone (VL) with rate constants of kobs = 3.0(1)•10–2, 1.2–2.7•10–2, and 0.11(1) min–1, respectively. Homopolymers showed narrow polydispersities of appr. 1.1. Sequential addition polymerizations showed evidence for transesterification (not seen in homopolymerizations) if BL or CL are introduced after a lactide block.

Keyphrases: Zinc, Magnesium, Copper, β-diketimine, Polymerization, rac-lactide, Lactide, Beta-butyrolactone, Epsilon-caprolactone, Delta-valerolactone